The complete nucleotide sequence of ermA, the prototype macrolide-lincosamide-streptogramin B resistance gene from Staphylococcus aureus, has been determined. The sequence predicts a 243-amino-acid protein that is homologous to those specified by ermC, ermAM, and ermD, resistance determinants from Staphylococcus aureus, Streptococcus sanguis, and Bacillus licheniformis, respectively. The ermA transcript, identified by Northern analysis and S1 mapping, contains a 5' leader sequence of 211 bases which has the potential to encode two short peptides of 15 and 19 amino acids; the second, longer peptide has 13 amino acids in common with the putative regulatory leader peptide of ermC. The coding sequence for this peptide is deleted in several mutants in which macrolide-lincosamide-streptogramin B resistance is constitutively expressed. Potential secondary structures available to the leader sequence of the wild-type (inducible) transcript and to constitutive deletion, insertion, and point mutations provide additional support for the translational attenuation model for induction of macrolide-lincosamide-streptogramin B resistance.
Inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics was identified in gram-positive organisms by Weaver and Pattee (47) shortly after the introduction of erythromycin into clinical practice. Resistance is associated with N6, N6-dimethylation of specific adenine residues in 23S rRNA (21) ; methylated ribosomes do not bind erythromycin. The enzymatic activity responsible is an S-adenosylmethionine-dependent methylase that is active on 23S rRNA (39) .
Resistance to the MLS spectrum of antibiotics is inducible by erythromycin (Em) and the closely related macrolide oleandomycin (Om). Induction occurs post-transcriptionally (40) by a mechanism resembling transcriptional attenuation (11, 16) .
The sequences of the Emr determinants analyzed to date indicate a strong evolutionary relationship among ermA, ermC (Staphylococcus aureus) (11, 16) , and ermAM (Streptococcus spp.) (15) ; ermD (Bacillus licheniformis) (12) is less closely related. Hybridization studies indicate that Streptomyces erythreus, the producer of erythromycin, contains nucleotide sequences homologous to ermD (18) . This supports the hypothesis of Benveniste and Davies (1) that antibiotic resistance genes evolved originally in the antibiotic-producing strains themselves. Although the methylase genes themselves are strikingly homologous and the overall regulatory mechanism is conserved, there is no nucleotide sequence homology in the regulatory leader regions of the ermC, ermAM, and ermD transcripts.
This report describes the sequence of ermA, the determinant for which the mechanism of erythromycin resistance was first described (20) . ErmA is found on the transposon TnS54 (28, 33) , which is derived from Staphylococcus aureus E1206. The ermA mRNA contains a 211-base leader that potentially encodes two short peptides, one of which has 13 of 19 amino acids in common with the ermC leader peptide. The sequences of the wild type, inducible leader, and of a number of constitutive mutants lend additional support to the translational attentuation model (11) for the regulation of expression of erythromycin resistance.
MATERIALS AND METHODS
Strains and plasmids. Bacterial strains and plasmids are shown in Table 1 . The transposon Tn554 (28, 33) , which specifies resistance to erythromycin and spectinomycin, was originally isolated in Staphylococcus aureus E1206 (20) . Constitutive mutants were selected by plating RN4689 on medium containing 10 ,ug of tylosin, carbomycin, clindamycin, or lincomycin per ml. As these antibiotics do not induce resistance, colonies arising on plates containing them are expected to contain mutations to constitutivity. The mutant strains were purified by transductional outcross, and plasmid DNA was prepared for sequence analysis.
Nucleotide sequencing. Sequences were determined by the dideoxy chain termination method of Sanger et al. (37) by using restriction fragments cloned into the M13 derivative mpll (27) . [ox-35S]-dATP (Amersham Corp.) and 8% gradient gels were used (3). The constitutive mutants were sequenced in situ (46) ; after digestion with BglII the DNA was heated to 90°C with twofold excess of primer for 3 min and quenched on ice. A synthetic oligonucleotide primer, 5'-GTGCACCAGTATCGCAG-3' (provided by the Laboratory of Applied Microbiology at the Public Health Research Institute of the City of New York), that anneals to the ermA leader was used.
Analysis of transcripts. In vivo RNA was prepared from 50 ml of late-logarithmic-phase cultures. Protoplasts (5, 30) were suspended in 2.5 ml of 5 M guanidium isothiocyanate (6) , and the suspension was layered on 6 M CsCl and centrifuged at 100,000 x g for 18 h (9). The RNA pellet was precipitated twice with 8 M guanidine HCl and three times with ethanol and was stored in 70% ethanol at -70°C. Just before the gels were loaded, the suspension was centrifuged, rinsed, dried, resuspended in gel loading buffer, and heated to 65°C for 5 min. Ten micrograms of each RNA was electrophoresed in a 1.5% agarose-formaldehyde gel (22) (25) and hybridized for 3 h at 42°C in 80% formamide-0.4 M NaCl-40 mM PIPES [piperazine-N, N'-bis(2-ethanesulfonic acid)] (pH6.5}-1 mM EDTA. The samples were diluted 10-fold with S1 buffer containing 500 U of S1 per ml and incubated a further 30 min at 37°C, extracted twice with phenol-chloroform, ethanol precipitated, and loaded on an 8% gradient sequencing gel.
Predicted secondary structure of the ermA leader. Free energy calculations for folded structures were based on the rules of Tinoco et al. (44) , by using the tabulated values of Salser (36) as modified by Cech et al (4) . The algorithm of Zucker and Stiegler (50) was useful in generating these structures. RESULTS Nucleotide sequence of ermA. The sequencing strategy and restriction map for erinA are depicted in Fig. 1 . ErmA roughly spans the region of 4.5 to 5.5 kilobases on the map of Tn554 (6,691 base pairs [bp] ), the complete sequence of which will be published elsewhere (manuscript in preparation) and is transcribed from left to right as written, opposite to the other known genes of Tn554. For this report the transcriptional start site of ermA, bp 5493 of TnS54, has been assigned bp 1. All but 23 bp of the ermA coding sequence, and all of the 5' and 3' flanking sequences, were obtained from both strands of the constitutive mutant ermIl. A total of 64% of the coding region was verified on at least one strand of the wild-type (inducible) strain, and the inducible leader region was sequenced in its entirety in both directions.
The nucleotide sequence of ermA is given in Fig. 2 Identification of the ermA transcript. Total RNA prepared in vivo was subjected to Northern blot hybridization analysis by using as a probe an 882-bp AccI-Fnu4H fragment containing 86% of the ermnA-coding region and the entire 5' flanking sequences (Fig. 3A) . A 40 , appropriate fragments were cloned into M13rnpll and sequenced. No mutation was detected between bp -70 and +280. This mutation may affect the copy number of the vector plasmid; it was not studied further. All of the remaining constitutive mutants analyzed map) within the 211-bp leader sequence (Fig. 2) . Most are deletions of 90 to 130 bp that remove SD2 and the entire coding sequence for the 19-amino-acid peptide 2. crb-12 contains a tandem duplication of 25 bp from SD3 through the first 12 bp of the ermA-coding sequence. Only one point mutation, lin-71, a C G G--G C transversion at nucleotide 131, was isolated. Possible effects of these mutations on the potential secondary structure of the ermA leader are discussed below.
DISCUSSION
Comparison of ermA and other methylases. The amino acid sequences of ermA (Staphylococcus aureus), ermC (Staphylococcus aureus), ermAM (Streptococcus sanguis), and ermD (B. licheniformis) are compared in Fig. 4 and Table 2 . The ermA protein is somew,hat more closely related to the other Staphylococcus aureus determinant, ermC, than to ermAM or ermD. Among the three closely related genes the nucleic acid homology is quite constant.
Codon usage. The codon usage for ermA (Fig. 5) (Fig. 2) , an acceptable fit to the canonical sequence TATAAT (34) . A second possibility, TACAAT, is adjacent to the first. Based on the spacing to the transcriptional start site, the former sequence is more likely to be the functional one, although the latter is a better fit. It is possible that both are used to some extent; this might account for some of the minor protected species in the Si experiments. A possible -35 sequence is indicated in Fig. 2 ; it is preceded by an A + G-rich sequence at about -40, noted by Murray and Rabinowitz (31) in their study of , and RN4491 (lane 3, ermII), were run on a 1.5% agarose-formaldehyde gel as described in the text and probed with an 882-bp Fnu4H-AccI fragment (see Fig. 1 ). Arrows mark the positions of pT181 DNA restriction fragments (19) . (B) Si analysis. RNA (100Lug) was hybridized with 5' and 3'-end-labeled ermA probes as described in the text and incubated for 30 min with 500 U of S1 per ml. Lanes 1 through 4, 417-bp Hinfl-RsaI fragment from wild type (RN4689). Lane tRNA; lahe 7, no Si; lane 8, sequencing ladder. The 5'-end-labeled probes were labeled with [-y-32PIATP and polynucleotide kinase and strand separated. Due to incomplete strand separation of the 417-bp probe, two higher-molecular-weight bands appear in lane 2, the result of protection by an RNA which is transcribed from the opposite strand of TnSS4 (leftward on Fig. 1 and 2 ). gram-positive promoters. Immediately 3' to the ermA stop codon is a 17-bp imperfect inverted repeat that may function as a rho-independent transcription terminator for both ermA and spc, the adjacent, convergently transcribed gene encod- (11, 16) , ermAM (15) , and ermD (12) methylases. The alignment of ermD is taken from Gryczan et al. (12) . The numbers across the top indicate the number of different amino acids at each position.
ing spectinomycin resistance (E. Murphy, Mol. Gen. Genet., in press).
Regulation of ermA. A detailed model for the regulation of ermC by translational attenuation has been proposed independently by two laboratories (11, 16) (14, 17) provided support for this model, as did the demonstration that induction requires translation of the leader peptide (8) by ribosomes that are capable of binding erythromycin (13) .
The regulation of ermA appears to be similar in its overall mechanism. In contrast to the single leader peptide of ermC, ermD, and ermAM, the ermA leader potentially encodes two small peplides of 15 Fig. 6 . Structures A and B are equally probable on thermodynamic grounds; structure A is likely to be kinetically favored, as segments 3 and 4 will pair before segment 5 has been completely transcribed. Neither structure A nor B can actively translate methylase because the initiation cbdon for ermA is base paired. In the presence of inducing concentrations of erythromycin, translation of peptide 1 by a ribosome that has bound erythromycin would result in ribosome stall in segment 1, freeing segment 2 and allowing translation of peptide 2. In turn, stalling in segment 3 by ribosomes translating peptide 2 will either directly free segment 6, which contains the AUG codon for ermA (structure B), or, for structure A, will free segment 4 to pair with 5, displacing segment 6, allowing translation and also causing isomerization of structure A to structure B. In either case, translation of ermA would be transient and completely dependent upon the continued presence of erythromycin as inducer, as there is no stable structure in which segment 6 is unpaired. The ermC mRNA, on the other hand, can potentially form a metastable structure in which methylase can be translated; this structure, although considerably less stable than the inactive structures, is the kinetically favored one and may contribute to the basal level of ermC methylase (11) .
Analysis of the mutations that result in constitutive expression of ermA provides biological support for the model. The point mutant lin-71 involves a base that pairs with the ermA AUG codon in structure B; this substitution not only destabilizes the pairing of segments 3 and 6 but also allows segment 3 to form a small hairpin loop between bp 129 and 143 that stabilizes the new structure. Segment 6 cannot form the equivalent hairpin, leaving the initiation codon unpaired. In structure A the effect of this mutation is to destabilize the pairing of segments 3 and 4, permitting isomerization to the mutant B-type structure. Iin-71 is located at the same position as a C G-uA. T transversion mutant of ermC (17) . Another mutation, crb-12, a 25-bp tandem duplication from SD3 through the first 12 bp of ermA, is similar to tyc-16, a 109-bp insertion mutation in ermC (14) . The most favorable structure for the crb-12 leader leaves the duplicated, 3' Shine-Dalgarno site unpaired; the alternative structures in which the duplicated region is involved in base pairing with segment 3 or 5 is unfavored on both thermodynamic and kinetic grounds. The remaining mutations contain deletions that remove most of the potential for secondary structure (Fig. 6) .
Peptide 2 has 13 of 19 amino acids in common with the ermC peptide; the nucleic acid homology in this region (SD2 to SD3) is much greater than that between the structural genes themselves (Fig. 7) . Those bases postulated to be involved in secondary structure are more highly conserved (86%) than those in non-base-paired regions (69%). This implies a very recent evolutionary divergence between ermA and ermC; they are the only two determinants whose regulatory regions are detectably related. The two sequences diverge upstream of SD2; this region is highly A + T-rich, and it is probably not coincidental that a number of the constitutive deletion mutations terminate at this point; the region seems to be a hot spot for recombinational events, possibly including one that gave rise to ermC and ermA from an ancestral gene.
The failure of antibiotics other than erythromycin and oleandomycin to act as inducers of ermC and of ermD has been ascribed to subtle differences between the mechanism of action of various MLS antibiotics. The transpeptidization reaction is most effectively blocked by erythromycin and oleandomycin when the nascent peptide is rather large; amino acids with bulky, hydrophilic side chains are most sensitive to inhibition (24) . Other macrolides and lincosamides inhibit transpeptidization when the peptidyl-tRNA donor is very small, preventing the formation of even the first peptide bond (23) . Thus the sequence and location of amino acids in the regulatory peptide have been postulated to contribute to the position at which ribosomes stall (11); premature stalling, or release of ribosomes, would not free the mRNA to refold into a structure in which the translation ®8) AGG-65. (Fig. 6 ).
initiation signals are unpaired. In the model proposed above for induction of ermA translation of peptide 1 is a prerequisite for translation of peptide 2; furthermore, erythromycininduced stall must occur near the C-terminal end of peptide 1 for induction to be effective. The hydrophilic regions (where stall is most likely to occur) of peptides 1 and 2, and of the ermC peptide, are located at the C-terminal ends, beginning with residue 13 in all three cases. The model also provides an explanation for the lack of any mutations affecting only peptide 1: deletion of peptide 1 would render the regulatory region essentially identical to that of ermC, and the resistance would remain inducible, whereas mutations that prevented the translation of peptide 1 without deletion of segment 1 (by mutation of SD1, for example) would result in an Ems phenotype, like those mutations obtained by Hahn et al (14) for ermC. Perhaps peptide 1 plays a role in the specificity of induction; mutants of ermA with altered induction specificity have been reported (43, 48) , although no mutants of this type were isolated in this study. In this regard it is interesting that the streptococcal ermAM determinant is inducible by the entire range of MLS antibiotics (49) ; it specifies a 155-base leader sequence encoding a 36-amino-acid peptide that can potentially form a large number of secondary structures (15) . The leader region of ermD is similarly complex, although it is inducible only by erythromycin and oleandomycin (12) . The sequences of these regulatory regions are not detectably related to one another or to peptide 1 of ermA.
Induction kinetics and basal levels: predictions. In the ermC system, SD1 is always available to translate the leader peptide. For ermA, SD1 is unpaired, but the AUG codon is involved in a short stem loop. The free energy contribution of this hairpin is only -4.8 kcal (-20.1 kJ); this may be sufficiently unstable to allow some translation to occur. In addition, since stall of peptides 1 and 2 must be sequential, induction requires that both of the ribosomes that initiate translation at SD1 and SD2 have bound erythromycin, a condition which will not be easily met at very low drug concentrations. This cascade of regulatory peptides, and the possibility that peptide 1 is not constantly translated, might affect the induction kinetics in such a way that the rate of induction at low concentrations of erythromycin is slower than that of ermC. This might allow the cell to avoid responding to extremely low levels of antibiotic. In addition, the absence of a metastable active structure, as noted above, may contribute to a lower basal level of ermA methylase, which would in turn predict poor induction with high concentrations of drug. These predictions remain to be tested.
